Mattes M
Curr Urol Rep. 2024; 25(8):181-192.
PMID: 38861238
DOI: 10.1007/s11934-024-01217-5.
Alexander S, Oelfke U, Westley R, McNair H, Tree A
Clin Transl Radiat Oncol. 2023; 43:100685.
PMID: 37842073
PMC: 10570575.
DOI: 10.1016/j.ctro.2023.100685.
Goudschaal K, Beeksma F, Boon M, Bijveld M, Visser J, Hinnen K
Radiat Oncol. 2021; 16(1):37.
PMID: 33608008
PMC: 7893889.
DOI: 10.1186/s13014-021-01768-8.
Hanjar A, Fahmawi Y, Ahmed Y, Kumar M, Merritt L, Mizrahi M
ACG Case Rep J. 2020; 7(7):e00426.
PMID: 32766368
PMC: 7357711.
DOI: 10.14309/crj.0000000000000426.
Liang X, Zhao W, Hristov D, Buyyounouski M, Hancock S, Bagshaw H
Med Phys. 2020; 47(9):4233-4240.
PMID: 32583418
PMC: 10823910.
DOI: 10.1002/mp.14355.
Evaluation of an Open Source Registration Package for Automatic Contour Propagation in Online Adaptive Intensity-Modulated Proton Therapy of Prostate Cancer.
Qiao Y, Jagt T, Hoogeman M, Lelieveldt B, Staring M
Front Oncol. 2019; 9:1297.
PMID: 31828037
PMC: 6890846.
DOI: 10.3389/fonc.2019.01297.
Evolution of definitive external beam radiation therapy in the treatment of prostate cancer.
Daly T
World J Urol. 2019; 38(3):565-591.
PMID: 30850855
DOI: 10.1007/s00345-019-02661-6.
A comparison of treatment outcome between fiducial-based and bone-based image guided radiotherapy in prostate cancer patients.
Napieralska A, Majewski W, Kulik R, Glowacki G, Miszczyk L
Radiat Oncol. 2018; 13(1):235.
PMID: 30482212
PMC: 6258434.
DOI: 10.1186/s13014-018-1171-2.
Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline.
Morgan S, Hoffman K, Loblaw D, Buyyounouski M, Patton C, Barocas D
J Clin Oncol. 2018; :JCO1801097.
PMID: 30307776
PMC: 6269129.
DOI: 10.1200/JCO.18.01097.
Experimental study of beam distortion due to fiducial markers during salvage HIFU in the prostate.
Bakaric M, Martin E, S Georgiou P, Cox B, Payne H, Treeby B
J Ther Ultrasound. 2018; 6:1.
PMID: 29588854
PMC: 5863876.
DOI: 10.1186/s40349-018-0109-3.
ACR Appropriateness Criteria for external beam radiation therapy treatment planning for clinically localized prostate cancer, part II of II.
Zaorsky N, Showalter T, Ezzell G, Nguyen P, Assimos D, DAmico A
Adv Radiat Oncol. 2017; 2(3):437-454.
PMID: 29114613
PMC: 5605284.
DOI: 10.1016/j.adro.2017.03.003.
Volumetric-modulated arc therapy and intensity-modulated radiation therapy treatment planning for prostate cancer with flattened beam and flattening filter free linear accelerators.
Treutwein M, Hipp M, Koelbl O, Dobler B
J Appl Clin Med Phys. 2017; 18(5):307-314.
PMID: 28857432
PMC: 5875831.
DOI: 10.1002/acm2.12168.
Dosimetric implications of inter- and intrafractional prostate positioning errors during tomotherapy : Comparison of gold marker-based registrations with native MVCT.
Wust P, Joswig M, Graf R, Bohmer D, Beck M, Barelkowski T
Strahlenther Onkol. 2017; 193(9):700-706.
PMID: 28466155
DOI: 10.1007/s00066-017-1141-x.
Integral Dose-Based Inverse Optimization May Reduce Side Effects in Radiotherapy of Prostate Carcinoma.
Mihaylov I
Front Oncol. 2017; 7:27.
PMID: 28299284
PMC: 5331038.
DOI: 10.3389/fonc.2017.00027.
Three-dimensional surface and ultrasound imaging for daily IGRT of prostate cancer.
Krengli M, Loi G, Pisani C, Beldi D, Apicella G, Amisano V
Radiat Oncol. 2016; 11(1):159.
PMID: 27955693
PMC: 5154119.
DOI: 10.1186/s13014-016-0734-3.
Initial results for patient setup verification using transperineal ultrasound and cone beam CT in external beam radiation therapy of prostate cancer.
Richter A, Polat B, Lawrenz I, Weick S, Sauer O, Flentje M
Radiat Oncol. 2016; 11(1):147.
PMID: 27825386
PMC: 5101794.
DOI: 10.1186/s13014-016-0722-7.
Deformable image registration for adaptive radiotherapy with guaranteed local rigidity constraints.
Konig L, Derksen A, Papenberg N, Haas B
Radiat Oncol. 2016; 11(1):122.
PMID: 27647456
PMC: 5029058.
DOI: 10.1186/s13014-016-0697-4.
Image-guided radiation therapy (IGRT): practical recommendations of Italian Association of Radiation Oncology (AIRO).
Franzone P, Fiorentino A, Barra S, Cante D, Masini L, Cazzulo E
Radiol Med. 2016; 121(12):958-965.
PMID: 27601141
DOI: 10.1007/s11547-016-0674-x.
Determining intrafractional prostate motion using four dimensional ultrasound system.
Baker M, Behrens C
BMC Cancer. 2016; 16:484.
PMID: 27422044
PMC: 4947261.
DOI: 10.1186/s12885-016-2533-5.
Quantification of the margin required for treating intraprostatic lesions.
Studenski M, Valenciaga Y, Abramowitz M, Stoyanova R, Bossart E, Dogan N
J Appl Clin Med Phys. 2016; 17(3):304-312.
PMID: 27167286
PMC: 5690932.
DOI: 10.1120/jacmp.v17i3.6089.